Table:
begin	end	state
1	36	non-cytoplasmic
37	58	transmembrane
59	65	cytoplasmic
66	86	transmembrane
87	105	non-cytoplasmic
106	127	transmembrane
128	134	cytoplasmic
135	155	transmembrane
156	183	non-cytoplasmic
184	203	transmembrane
204	209	cytoplasmic
210	228	transmembrane
229	260	non-cytoplasmic
261	283	transmembrane
284	297	cytoplasmic
298	320	transmembrane
321	333	non-cytoplasmic
334	374	transmembrane
375	391	non-cytoplasmic
392	420	transmembrane
421	569	cytoplasmic

Input:
>WP_011386051.1 NCBI__GCF_000009985.1:WP_011386051.1
MSERPTFMPARLINLFTPKLLVCLKEGYDLPRGRGDLIAGLTVAIVALPLAMALGIASGV
TPDRGLFTAIVAGFLISFLGGSRFQIGGPTGAFVVVVYNIVQQHGYDGLVLATLMAGVML
LLFGLARFGVVIKYIPYPLVTGFTSGIAVIIFSSQVKDFLGLRMESVPAEFFEKWVAYGE
HIGTTHGPTLAVAAGTLAVILVLRRFRPGWPGFLIGVTGASVLVWALGMPVETIGSRFGG
IPSTLPSPQFPALSWGKVTALLQPAFTIAFLAGIESLLSAMVADGMTGRRHKSNCELLAQ
GIANIASVLFGGIPATGAIARTATSIKSGAQTPVAGMLHAVFILLFMLLFAPLASWIPLP
SLAAVLMVVAWNMSEAPHFIHLMSAPRSDRAVLLVTFVLTVMVDLTVAIEVGMVLASILF
MRRMAEVTEIGTGIHLIDEDAEDGGDDHVGAIPTTPIPDGVEVFQISGPFFFGVATRLSE
VFEQTHKPPRVFILRMRLVPVIDASGIQALTEFVRRCRKHGTEVLLSGVQPQPMQVMGRM
GLCHEIGEDNFVPNIDAALTTARTLAVHP

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server